A
Alice Pau
Researcher at National Institutes of Health
Publications - 23
Citations - 2230
Alice Pau is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Medicine & Immune reconstitution inflammatory syndrome. The author has an hindex of 10, co-authored 17 publications receiving 2053 citations.
Papers
More filters
DatasetDOI
Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.
TL;DR: The most recent version of the guidelines for the prevention and treatment of opportunistic infections (OI) in HIV-infected adults and adolescents was published in 2002 and 2004, respectively as mentioned in this paper.
Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America.
TL;DR: These guidelines are intended for clinicians and other health-care providers who care for HIV-infected adults and adolescents, including pregnant women, and include evidence-based guidelines for treatment of 28 OIs caused by protozoa, bacteria, fungi, and viruses.
Journal ArticleDOI
Defective HIV-1 proviruses produce viral proteins
Hiromi Imamichi,Mindy Smith,Joseph W. Adelsberger,Taisuke Izumi,Francesca Scrimieri,Brad T. Sherman,Catherine Rehm,Tomozumi Imamichi,Alice Pau,Marta Catalfamo,Anthony S. Fauci,H. Clifford Lane +11 more
TL;DR: It is demonstrated that defective proviruses that persist in HIV-infected individuals during suppressive cART are translationally competent and produce the HIV-1 Gag and Nef proteins, which may trigger an element of innate immunity.
Journal ArticleDOI
HIV-Associated Opportunistic Infections—Going, Going, But Not Gone: The Continued Need for Prevention and Treatment Guidelines
TL;DR: In the United States, the incidence of HIVassociated opportunistic infections (OIs) has decreased dramatically, resulting from improvements in and the diffusion of effective OI prophylaxis, but most importantly, they have resulted from the advent of combination antiretroviral therapy.
Journal ArticleDOI
Treating Opportunistic Infections among HIV-Infected Adults and Adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America
TL;DR: The CDC National Institutes of Health and the HIV Medicine Association of the Infectious Diseases Society of America have developed guidelines for treatment of opportunistic infections (OIs) among adults and adolescents infected with human immunodeficiency virus (HIV).